News - 29 May `23Data-Driven Drug Development in Vitiligo

New

Data-Driven Drug Development in Vitiligo

In an interview with Dermatology Times, Stefan Weiss, MD from OM1, a data analytics company, highlighted how leveraging large-scale data analytics can enhance dermatological care, especially for conditions like vitiligo. By creating detailed datasets, OM1 aims to personalize treatment, ensuring patients receive the most effective drugs for their specific conditions. This method promises improved outcomes by analyzing diverse patient responses.

Their study, presented at the ISPOR Annual Conference in Boston, utilized the OM1 Dermatology Network to examine vitiligo's impact, exploring demographics, mental health, and treatment trends in 26,016 patients, based on healthcare claims and patient records from 2013 to 2022. Findings reveal a majority female demographic, diverse racial composition, and common use of treatments like corticosteroids and UVB phototherapy. 

Download poster "Patient Characteristics and Social Determinants of Health in a Large Real-World Cohort of Vitiligo Patients in the U.S." in full size here below. 

 

 



    FAQOther Questions

    • Can Ayurveda help with vitiligo?

      Ayurveda, the ancient Indian system of holistic medicine, focuses on balancing body energies (Doshas) and improving digestion. While it offers a valuable perspective on "whole-b...

    • Pyrostegia venusta as a folk medicine for vitiligo?

      Pyrostegia venusta, also known as “flame vine” or “cipó-de-são-joão,” is a neotropical evergreen vine native to Brazil. It thrives in fields, coastal areas, forest edges, and ro...

    • Is it possible to stop the progression of vitiligo?

      While it's not always possible to quickly stop vitiligo progression, there are some treatments that can help slow or halt the spread of the condition in many cases: Corticostero...